22 studies found for:    "Desmoid tumor"
Show Display Options
Rank Status Study
1 Active, not recruiting Phase II Trial of the Gamma-Secretase Inhibitor PF-03084014 in Adults With Desmoid Tumors/Aggressive Fibromatosis
Conditions: Desmoid Tumors;   Aggressive Fibromatosis
Intervention: Drug: PF-03084014
2 Active, not recruiting Study to Evaluate Imatinib in Desmoid Tumors
Conditions: Aggressive Fibromatosis;   Desmoid Tumor
Intervention: Drug: Imatinib
3 Completed Toremifene in Treating Patients With Desmoid Tumors
Condition: Desmoid Tumor
Interventions: Drug: toremifene;   Procedure: conventional surgery
4 Completed Vinblastine and Methotrexate in Treating Children With Desmoid Tumors
Condition: Desmoid Tumor
Interventions: Drug: methotrexate;   Drug: vinblastine sulfate
5 Recruiting PAZOPANIB Efficacy and Tolerance in Desmoids Tumors
Condition: Progressive Desmoids Tumors
Interventions: Drug: PAZOPANIB treatment;   Drug: Active Comparator: Vinblastine and Methotrexate
6 Recruiting A Pilot Study Evaluating the Use of mTor Inhibitor Sirolimus in Children and Young Adults With Desmoid-Type Fibromatosis
Condition: Desmoid Tumor
Intervention: Drug: Sirolimus
7 Completed Radiation Therapy in Treating Patients With Aggressive Fibromatoses
Condition: Desmoid Tumor
Intervention: Radiation: radiation therapy
8 Completed A Cohort Study of Patients Treated With Brachytherapy for Selected Desmoid Patients in Gardner Syndrome
Conditions: Gardner Syndrome;   Colorectal Carcinoma;   Desmoid Tumor
Intervention:
9 Withdrawn Effect of Hydroxyurea as Treatment for Primary Desmoid Tumors
Conditions: Desmoid Tumors;   Fibromatosis
Intervention: Drug: Hydroxyurea
10 Active, not recruiting
Has Results
Sulindac and Tamoxifen in Treating Patients With Desmoid Tumor
Condition: Desmoid Tumor
Interventions: Drug: tamoxifen citrate;   Drug: sulindac;   Other: laboratory biomarker analysis
11 Recruiting Sorafenib Tosylate in Treating Patients With Desmoid Tumors or Aggressive Fibromatosis
Condition: Desmoid Tumor
Interventions: Drug: sorafenib tosylate;   Other: placebo;   Other: laboratory biomarker analysis;   Other: quality-of-life assessment
12 Recruiting Imatinib in Patients With Desmoid Tumor and Chondrosarcoma
Conditions: Advanced Desmoid Tumor;   Advanced Chondrosarcoma
Intervention: Drug: Imatinib Mesylate
13 Recruiting Safety and Efficacy Study Using 5-ALA Oral Administration as an Adjuvant Therapy on the Rate of Local Tumor Recurrence in Patients Who Have Desmoids Tumors
Conditions: The Aim of the Study is to Evaluate the Efficacy of Photodynamic Therapy as an;   Adjuvant Therapy on the Clinical Outcome of Patients With Desmoid Tumors After;   Surgical Resection
Intervention: Drug: 5-AMINOLEVULINIC ACID (5-ALA), is a non fluorescent prodrug.
14 Unknown  Imatinib Mesylate in Treating Patients With Recurrent or Refractory Fibromatosis
Condition: Desmoid Tumor
Intervention: Drug: imatinib mesylate
15 Recruiting Endoxifen in Adults With Hormone Receptor Positive Solid Tumors
Conditions: Hormone Receptor-Positive Breast;   Gynecologic;   Desmoid;   Hormone Receptor-Positive Neoplasms
Intervention: Drug: Z-Endoxifen
16 Unknown  Studying Genes in Tissue Samples From Younger and Adolescent Patients With Soft Tissue Sarcomas
Conditions: Chordoma;   Desmoid Tumor;   Sarcoma
Interventions: Genetic: DNA analysis;   Genetic: microarray analysis;   Genetic: polymerase chain reaction;   Other: laboratory biomarker analysis;   Other: mass spectrometry
17 Completed Sunitinib in Treating Patients With Metastatic, Locally Advanced, or Locally Recurrent Sarcomas
Conditions: Adult Malignant Fibrous Histiocytoma of Bone;   Desmoid Tumor;   Endometrial Cancer;   Ovarian Cancer;   Sarcoma;   Small Intestine Cancer
Intervention: Drug: sunitinib malate
18 Recruiting Collecting and Storing Tissue, Blood, and Bone Marrow Samples From Patients With Rhabdomyosarcoma or Other Soft Tissue Sarcoma
Conditions: Adult Rhabdomyosarcoma;   Childhood Desmoplastic Small Round Cell Tumor;   Chordoma;   Desmoid Tumor;   Metastatic Childhood Soft Tissue Sarcoma;   Nonmetastatic Childhood Soft Tissue Sarcoma;   Previously Treated Childhood Rhabdomyosarcoma;   Previously Untreated Childhood Rhabdomyosarcoma;   Recurrent Adult Soft Tissue Sarcoma;   Recurrent Childhood Rhabdomyosarcoma;   Recurrent Childhood Soft Tissue Sarcoma;   Stage I Adult Soft Tissue Sarcoma;   Stage II Adult Soft Tissue Sarcoma;   Stage III Adult Soft Tissue Sarcoma;   Stage IV Adult Soft Tissue Sarcoma
Interventions: Other: biologic sample preservation procedure;   Other: laboratory biomarker analysis
19 Completed
Has Results
Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain
Condition: Cancer
Interventions: Drug: Fentanyl sublingual spray;   Drug: Placebo
20 Completed MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma
Condition: Cancer
Intervention: Drug: entinostat

Previous Page Studies Shown (1-20) Next Page (21-22) Show next page of results
Indicates status has not been verified in more than two years